Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2778
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Campath (Injection)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:genericDr... | |
| dailymed-instance:boxedWarn... |
WARNING: CYTOPENIAS, INFUSION REACTIONS, and INFECTIONS: Cytopenias : Serious, including fatal, pancytopenia/marrow hypoplasia,
autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia
can occur in patients receiving Campath. Single doses of Campath greater
than 30 mg or cumulative doses greater than 90 mg per week increase the
incidence of pancytopenia[see WARNINGS AND
PRECAUTIONS (5.1)]. Infusion Reactions : Campath administration can result in serious, including
fatal, infusion reactions. Carefully monitor patients during infusions
and withhold Campath for Grade 3 or 4 infusion reactions. Gradually
escalate Campath to the recommended dose at the initiation of therapy
and after interruption of therapy for 7 or more days[see DOSAGE AND
ADMINISTRATION
(2) and WARNINGS AND
PRECAUTIONS (5.2)]. Infections : Serious, including fatal, bacterial, viral, fungal, and
protozoan infections can occur in patients receiving Campath. Administer
prophylaxis against Pneumocystis jiroveci pneumonia (PCP) and herpes virus infections [see DOSAGE AND
ADMINISTRATION (2.2) and WARNINGS AND
PRECAUTIONS (5.3)].
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:possibleD... |
diseasome-diseases:1173,
diseasome-diseases:1693,
diseasome-diseases:1694,
diseasome-diseases:181,
diseasome-diseases:2789,
diseasome-diseases:3004,
diseasome-diseases:3020,
diseasome-diseases:3365,
diseasome-diseases:4136,
diseasome-diseases:602,
diseasome-diseases:698,
diseasome-diseases:701,
diseasome-diseases:833
|
| dailymed-instance:genericMe... |
alemtuzumab
|
| dailymed-instance:fullName |
Campath (Injection)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Campath
|